GLRA
AVNS

Gerald L. Ray & Associates’s Avanos Medical AVNS Stock Holding History

Gerald L. Ray & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,403
Closed -$281K – 297
2015
Q4 		$281K Buy
8,403
+177
+2% +$5.5K 0.04% 239
2015
Q3 		$234K Sell
8,226
-745
-8% -$26K 0.04% 269
2015
Q2 		$363K Buy
8,971
+500
+6% +$22.4K 0.06% 236
2015
Q1 		$416K Buy
+8,471
New +$392K 0.06% 224

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Gerald L. Ray & Associates's AVNS Position: Q1 2016 in Review

Gerald L. Ray & Associates sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 8,403 shares — an estimated $281K sold.

Gerald L. Ray & Associates first reported a position in AVNS in Q1 2015 and held it in 4 quarters. The position peaked at $416K in Q1 2015. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Gerald L. Ray & Associates reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
  • Gerald L. Ray & Associates sold 8,403 Avanos Medical shares in Q1 2016, an estimated $281K.
  • Gerald L. Ray & Associates first reported a position in Avanos Medical in Q1 2015 and held it in 4 quarters.
  • Gerald L. Ray & Associates's Avanos Medical position peaked at $416K in Q1 2015.
  • 333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Gerald L. Ray & Associates's 13F filing for Q1 2016, filed 5 May 2016.